HES5 promotes cell proliferation and invasion through activation of STAT3 and predicts poor survival in hepatocellular carcinoma

Experimental and Molecular Pathology
Guizhou ZhuChun Cheng

Abstract

HES5 is a member of the basic helix-loop-helix (bHLH) family of transcription factors, and involved in cell differentiation and proliferation in a variety of tissues other than HCC. Therefore, we have characterized HES5 and investigated its role during hepatocarcinogenesis. We first examined the expression of HES5 in eight paired frozen HCC and adjacent noncancerous liver tissues by Western blot. Immunohistochemistry was performed to confirm our results in 58 HCC samples and evaluated the relativity between the expression of HES5 and clinicopathological variables and estimated the prognostic significance. Moreover, Western blot examined the expression of downstream proteins by siRNA HES5. Flow cytometer assay was performed to investigate the role of HES5 in the process of HCC. We found that HES5 was upregulated in HCC specimens. The data showed that high expression of HES5 was tightly associated with histological grade (P<0.01) and metastasis (P<0.01), and positively correlated with proliferation marker Ki-67 (P<0.01). Moreover, the results show that abnormal expression of HES5 influences cell growth and cell cycle of HCC cell lines. Furthermore, HES5 knockdown resulted in the reduction of p-STAT3. These results suggested that ...Continue Reading

References

May 25, 2004·Nature Cell Biology·Sachiko KamakuraYukiko Gotoh
Sep 15, 2005·JAMA : the Journal of the American Medical Association·Ahmedin JemalMichael Thun
Jun 27, 2006·Nature·Andreas Androutsellis-TheotokisRonald D G McKay
Nov 10, 2006·Cell and Tissue Research·Camilla KarlssonAnders Lindahl
Feb 13, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Christopher D MannDavid P Berry
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
May 13, 2008·Gastroenterology·Hashem B El-SeragK Rajender Reddy
Aug 19, 2009·Experimental and Molecular Pathology·Qing KeAiguo Shen
Aug 20, 2009·Journal of Cancer Research and Clinical Oncology·Hua YangRou Li Zhou
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Jan 26, 2011·Annals of Surgery·Nuh N RahbariJürgen Weitz
Jun 3, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Heng-Chao YuHua Han
Oct 14, 2011·The New England Journal of Medicine·Hashem B El-Serag
Jul 11, 2013·Pathology Oncology Research : POR·Cuihua LuXiaodong Huang
Oct 9, 2013·Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer·Vandana MoudgilJasbir Singh
Feb 3, 2015·Anti-cancer Agents in Medicinal Chemistry·Lichun SunDavid H Coy

❮ Previous
Next ❯

Citations

Sep 14, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xinghua ZhuSong He
Nov 13, 2019·Digestive Diseases and Sciences·Guijuan ZongXudong Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.